Introduction A comprehensive Nitrosamine Risk Assessment for ANDA Submission requires a structured and scientific evaluation of potential nitrosamine formation pathways. […]
How to Prepare a Complete Nitrosamine Risk Assessment Report for ANDA Submission Read More »
Introduction Nitrosamine Testing in Stability Studies is no longer limited to initial risk mitigation. It has evolved into an ongoing,
Nitrosamine Testing in Stability Studies: Designing Long-Term Monitoring Programs Read More »
Summary — Key Insights at a Glance Introduction: Packaging Leachables Nitrosamine E&L—The Critical Link in Pharmaceutical Safety The connection between
Leachables and Extractables (E&L): Linking Packaging to Nitrosamine Contamination Read More »
Introduction In active pharmaceutical ingredient (API) manufacturing, Nitrosamine Solvent Catalyst Mitigation has become one of the most important topics for
Mitigating Nitrosamine Formation from Solvents and Catalysts in API Manufacturing Read More »
Introduction: The Role of Secondary Amine Scavenger Nitrosamine in Drug Product Stability The use of Secondary Amine Scavenger Nitrosamine control
Secondary Amine Scavenging Strategies and the Impact on Drug Product Stability Read More »
Summary Introduction: Why Advanced Nitrosamine Purge Factor Calculation Is the Regulatory Game-Changer In today’s pharmaceutical impurity control landscape, Nitrosamine Purge
Advanced Purge Calculation Methodologies and Regulatory Acceptance Read More »
Summary (Key Takeaways) Introduction: The Overlooked Role of Excipients in Nitrosamine Risk For many years, the pharmaceutical industry focused mainly
Identifying and Controlling Excipient Contamination as a Nitrosamine Source Read More »
🔍 Summary (Quick Insights) Introduction A robust NDSRI Risk Assessment Methodology is now a core element of modern pharmaceutical impurity
Deep Dive: Risk Assessment for Nitrosamine Drug Substance-Related Impurities (NDSRIs) Read More »
Summary (Key Takeaways) Introduction: Defining Nitrosamine Specification Setting in the Pharmaceutical Context Nitrosamine Specification Setting refers to the systematic process
Establishing Specifications for Nitrosamines in Drug Substances and Drug Products Read More »
Introduction: Understanding the Impact of ICH M7(R2) Updates on Nitrosamine Risk Assessment The Impact of ICH M7(R2) Updates on Nitrosamine
The Impact of ICH M7(R2) Updates on Nitrosamine Risk Assessment and Control Read More »
